Comparative Study
doi: 10.1007/BF02554912.
Effects of prednisone and deflazacort on vertebral bone mass
- PMID: 3937579
- DOI: 10.1007/BF02554912
Item in Clipboard
Comparative Study
Effects of prednisone and deflazacort on vertebral bone mass
Calcif Tissue Int.
1985 Dec.
Abstract
The effects of a 12-month therapeutic course of two different glucocorticoids, prednisone and deflazacort (an oxazoline derivative of prednisolone), on vertebral and femoral bone was analyzed by dual photon absorptiometry. The data, which reveal a significantly less bone loss with deflazacort (9.7% in 12 months) than with prednisone (21.4% in 12 months), further document the advantage of deflazacort as a glucocorticoid medication in subjects with osteopenic syndromes.
Similar articles
-
A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: prednisone versus deflazacort.Calcif Tissue Int. 1998 Mar;62(3):199-204. doi: 10.1007/s002239900417. Calcif Tissue Int. 1998. PMID: 9501951 Clinical Trial.
-
A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders.Arthritis Rheum. 1991 Mar;34(3):287-95. doi: 10.1002/art.1780340306. Arthritis Rheum. 1991. PMID: 2003854 Clinical Trial.
-
Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.J Rheumatol. 2001 Nov;28(11):2474-9. J Rheumatol. 2001. PMID: 11708421 Clinical Trial.
-
[Glucocorticoids and risk of osteoporosis. On the problem of equivalent dose of desirable and undesirable effects of various glucocorticoids, exemplified by deflazacort].Med Klin (Munich). 1993 Jul 15;88(7):432-7. Med Klin (Munich). 1993. PMID: 8377721 Review. German. No abstract available.
-
Deflazacort. A review of its pharmacological properties and therapeutic efficacy.Drugs. 1995 Aug;50(2):317-33. doi: 10.2165/00003495-199550020-00008. Drugs. 1995. PMID: 8521761 Review.
Cited by
-
CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist.Br J Pharmacol. 2001 Aug;133(8):1405-13. doi: 10.1038/sj.bjp.0704210. Br J Pharmacol. 2001. PMID: 11498528 Free PMC article.
-
Skeletal Muscle Response to Deflazacort, Dexamethasone and Methylprednisolone.Cells. 2019 May 1;8(5):406. doi: 10.3390/cells8050406. Cells. 2019. PMID: 31052442 Free PMC article.
-
Differential effects of glucocorticoids on human osteoblastic cell metabolism in vitro.Calcif Tissue Int. 1995 Aug;57(2):120-6. doi: 10.1007/BF00298432. Calcif Tissue Int. 1995. PMID: 7584872
-
Serum osteocalcin (bone Gla-protein) following corticosteroid therapy in postmenopausal women with rheumatoid arthritis. Comparison of the effect of prednisone and deflazacort.Clin Rheumatol. 1988 Sep;7(3):366-71. doi: 10.1007/BF02239194. Clin Rheumatol. 1988. PMID: 3265902
-
Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.Calcif Tissue Int. 1992 Jun;50(6):490-7. doi: 10.1007/BF00582160. Calcif Tissue Int. 1992. PMID: 1525702 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical